sever
acut
respiratori
syndrom
sar
caus
novel
coronaviru
call
sar
coronaviru
sarscov
main
clinic
featur
respiratori
system
involv
addit
gastrointestin
symptom
also
common
nichol
et
al
sever
affect
patient
develop
acut
respiratori
distress
syndrom
correspond
diffus
alveolar
damag
acut
lung
injuri
complex
multifunct
pathophysiolog
process
involv
inflammatori
cytokin
releas
stimul
macrophag
alveoli
lead
dysregul
immun
system
nichol
et
al
cytokin
profil
sera
sar
patient
show
interleukin
il
interferon
ifn
g
promot
inflamm
induc
cell
injuri
significantli
increas
induct
level
close
correl
sever
sar
zhang
et
al
huang
et
al
well
known
induc
express
suppressor
cytokin
neg
regul
signal
phosphorylationactiv
yasukawa
et
al
hand
lead
reduct
lung
tissu
injuri
increas
convalesc
sar
patient
zhang
et
al
result
indic
sever
immun
respons
rather
viru
virul
contribut
progress
damag
lung
sar
cytokin
may
play
import
role
onset
pathogenesi
sar
howev
regul
system
cytokin
product
signal
sarscov
infect
poorli
understood
infect
virus
suscept
host
cell
bring
induct
variou
cytokin
type
includ
ifn
il
involv
antivir
defens
front
immun
regul
ifn
system
power
defens
mechan
viru
infect
system
divid
two
process
name
ifn
product
process
first
subsequ
establish
antivir
state
due
ifninduc
protein
oligoadenyl
synthetas
dsrnaacitiv
protein
kinas
pkr
ifnstimul
gene
myxoviru
resist
protein
mxa
samuel
sen
ransohoff
fujii
gongora
et
al
goodbourn
et
al
activ
ifnjakstat
signal
pathway
ifn
product
process
consist
two
step
former
involv
ifnb
product
activ
ifn
regulatori
factor
viru
earli
stage
infect
latter
product
larg
amount
ifna
primarili
induc
ifnb
format
transcript
heterodim
mani
virus
abl
suppress
ifn
system
variou
point
suppress
ifnb
product
ifnjakstat
signal
pathway
result
reduct
ifna
induct
antivir
function
report
influenza
viru
fluav
human
parainfluenza
viru
type
reduc
ifnb
induct
suppress
phosphoryl
talon
et
al
pool
et
al
furthermor
respiratori
syncyti
viru
rsv
counteract
ifn
signal
degrad
andrejeva
et
al
ramaswami
et
al
therefor
effect
ifn
replic
virus
diminish
contrast
ifn
favor
candid
therapeut
agent
sar
exhibit
antisarscov
activ
vitro
experi
vivo
treatment
trial
zhao
et
al
cinatl
et
al
sainz
et
al
morgenstern
et
al
line
evid
sarscov
seem
sensit
ifn
import
clarifi
influenc
sarscov
upon
ifn
system
name
suppress
ifn
product
counteract
ifn
signal
sarscov
infect
mani
virus
evolv
varieti
strategi
counteract
antivir
effect
ifn
aim
studi
analyz
innat
immun
respons
induc
sarscov
infect
particular
induct
thought
play
key
role
patient
sar
analysi
regul
system
product
signal
pathway
also
essenti
understand
pathogenesi
sar
inde
investig
induct
level
crucial
factor
act
neg
regul
signal
character
cytokin
regul
system
sar
examin
influenc
sarscov
upon
ifn
system
cytokin
product
infect
cell
compar
cell
infect
rsv
fluav
human
colon
carcinoma
cell
line
bronchiolar
carcinoma
cell
line
cervic
squamou
carcinoma
cell
line
siha
obtain
american
type
cultur
collect
manassa
va
cell
maintain
minimum
essenti
medium
gibcoinvitorogen
carlsbad
ca
contain
vv
heatinactiv
fetal
bovin
serum
gibcoinvitorogen
uml
penicillin
mgml
streptomycin
sarscov
strain
hanoi
provid
dr
morita
nagasaki
univers
japan
hong
et
al
concentr
viru
expos
uv
light
order
inactiv
viru
rsv
strain
long
describ
previous
tsutsumi
et
al
fluav
clinic
isol
type
patient
influenza
hokkaido
japan
human
provid
dr
ito
mie
univers
school
medicin
mie
japan
viru
infect
done
moi
viru
titer
tissu
cultur
infect
sarscov
determin
use
vero
cell
describ
previous
kariwa
et
al
human
ifna
ifnb
purchas
serotec
oxford
uk
genzymetechn
minneapoli
mn
respect
use
final
concentr
iu
ml
experi
perform
three
time
rna
analysi
total
cellular
rna
prepar
cell
line
use
isogen
accord
manufactur
protocol
nippon
gene
toyama
japan
rtpcr
assay
perform
use
onestep
rtpcr
kit
qiagen
hilden
germani
quantit
natur
pcr
valid
linear
determin
curv
variou
concentr
rna
sequenc
primer
sigmagenosi
ishikari
japan
given
tabl
dehydrogenas
gapdh
mrna
determin
control
experi
perform
triplic
three
cell
line
siha
investig
permiss
sarscov
infect
angiotensin
convert
enzym
identifi
receptor
sarscov
differ
cell
type
li
et
al
inde
express
high
level
primari
target
cell
sarscov
lo
therefor
examin
express
level
mrna
cell
line
rtpcr
found
markedli
higher
express
level
mrna
siha
cell
fig
furthermor
cytopath
effect
cpe
caus
sarscov
develop
cell
hr
post
infect
larg
amount
infect
cell
die
third
day
post
infect
siha
cell
show
cpe
day
infect
viru
mrna
sarscov
protein
found
cell
infect
sarscov
rtpcr
infect
siha
cell
report
mani
virus
includ
rsv
fluav
evolv
sever
antiifn
function
talon
et
al
andrejeva
et
al
pool
et
al
ramaswami
et
al
howev
still
unclear
whether
sarscov
abl
induc
sever
type
ifn
investig
ifninduc
sarscov
infect
compar
express
level
sever
ifn
ifnb
mrna
sarscov
infect
cell
virus
rsv
fluav
infect
cell
viral
infect
cell
harvest
isol
cellular
rna
appear
cpe
caus
infect
viru
shown
figur
type
ifn
littl
induc
furthermor
littl
lower
level
ifna
ifnb
ifn
induct
found
fluav
infect
cell
inde
bioassay
system
detect
ifn
activ
cultur
medium
fluav
infect
cell
contrast
signific
level
ifna
ifnb
ifnl
mrna
detect
sarscov
rsv
infect
cell
iuml
ifn
activ
recogn
cultur
medium
virus
infect
cell
express
level
ifnb
mrna
sarscov
alway
higher
rsv
infect
induct
ifnb
subsequ
express
essenti
process
produc
ifna
found
express
level
sarscov
rsv
infect
cell
significantli
higher
respiratori
viru
infect
differ
express
level
among
virus
seem
correl
level
ifn
product
includ
ifnl
howev
small
amount
ifna
induc
fluav
infect
although
induc
ifna
induct
may
due
activ
contribut
ifna
induct
independ
pathway
island
et
al
furthermor
correl
product
ifn
express
ifnstimul
gene
isg
mxa
express
isg
sarscov
rsv
infect
cell
higher
fluav
infect
cell
low
level
isg
induct
fluav
may
caus
low
titer
detect
bioassay
system
secret
ifn
cultur
medium
antivir
activ
sever
viral
protein
known
suppress
ifn
signal
transduct
pathway
assess
whether
sarscov
infect
interfer
ifn
signal
investig
mrna
express
level
isg
pkr
mxa
viru
infect
cell
mrna
level
isg
uninfect
increas
treatment
ifna
ifnb
hr
fig
control
infect
cell
sarscov
day
infect
cell
treat
ifna
ifnb
hr
shown
figur
mrna
induct
level
isg
infect
cell
similar
uninfect
cell
treat
ifn
contrast
isg
mrna
induc
ifn
treatment
infect
cell
data
shown
due
suppress
ifn
signal
pathway
result
show
sarscov
counteract
strategi
establish
ifninduc
antivir
state
ifn
signal
postul
sarscov
replic
effici
subdu
ifn
fact
counteract
activ
ifn
viru
infect
cell
treat
ifna
ifnb
hr
examin
antivir
effect
ifn
viru
infect
transcript
viru
gene
e
n
virusinfect
cell
significantli
reduc
second
day
pi
fig
ifnb
particular
disclos
potent
antivir
activ
ifna
result
also
confirm
reduct
infecti
progeni
viru
product
tabl
ii
initi
step
immun
respons
viral
infect
induct
proinflammatori
cytokin
chemokin
strictli
regul
defens
system
innat
immun
howev
recent
studi
show
overexert
immunerespons
sarscov
infect
may
contribut
progress
damag
lung
clarifi
characterist
cytokin
induct
profil
cell
infect
sarscov
compar
mrna
induct
pattern
cytokin
sarscov
respiratori
virus
express
increas
viral
infect
examin
level
almost
among
virus
ngml
protein
level
except
fluav
fig
anoth
chemokin
regul
upon
activ
normal
tcell
express
secret
rant
also
induc
sarscov
rsv
infect
j
med
virol
doi
ngml
protein
level
wherea
detect
fluav
infect
similarli
rant
proinflammatori
cytokin
dramat
increas
ident
level
sarscov
rsv
infect
ngml
protein
level
fluav
infect
contrast
uvinactiv
sarscov
fig
rsv
data
shown
abl
induc
mrna
express
cytokin
induct
profil
consist
result
obtain
sera
patient
sar
zhang
et
al
gener
cytokin
signal
pathway
correctli
regul
neg
feedback
factor
soc
famili
factor
also
induc
respons
stimul
appropri
cytokin
includ
ifn
via
jakstat
signal
pathway
case
tyrosin
kinas
recruit
receptor
turn
activ
induc
feedback
inhibitor
act
neg
regul
signal
therefor
import
normal
signal
transduct
pathway
less
induct
result
continu
activ
lead
enhanc
prolong
signal
crucial
investig
induct
level
sarscov
rsv
infect
cell
express
mrna
detect
viru
infect
cell
level
rsv
infect
remark
higher
sarscov
infect
fig
express
found
fluav
infect
produc
anoth
specif
neg
regul
signal
pathway
cytokineinduc
protein
ci
also
found
rsv
infect
fig
yoshimura
result
indic
dysfunct
neg
feedback
system
cytokin
signal
bring
strong
induct
inflammatori
reaction
tolllik
receptor
tlr
play
crucial
role
pattern
recognit
variou
microbi
compon
takeda
akira
tlr
trigger
host
defens
respons
via
gene
express
inflammatori
cytokin
innat
immun
respons
report
essenti
recognit
gramneg
bacteri
lipopolysaccharid
lp
unmethyl
cpg
dna
respect
poltorak
et
al
hemmi
et
al
lund
et
al
mrna
express
tlr
upregul
similar
extent
sarscov
rsv
fluav
infect
weak
induct
found
infect
fig
uv
inactiv
sarscov
never
influenc
cytokin
regul
studi
investig
influenc
sarscov
ifn
system
proinflammatori
cytokin
product
clarifi
pathogenesi
viru
suscept
ifn
front
line
defens
viru
infect
requir
ifnb
product
viru
infect
cell
follow
establish
antivir
function
activ
ifnjakstat
signal
transduct
pathway
stark
et
al
ifn
system
also
known
innat
immun
system
result
show
rsv
fluav
produc
less
ifnb
sarscov
infect
multifunct
protein
fluav
v
protein
inhibit
activ
follow
suppress
ifnb
product
talon
et
al
pool
et
al
human
counteract
ifn
signal
degrad
andrejeva
et
al
limit
product
ifnb
dysfunct
jakstat
signal
pathway
subsequ
express
isg
undetect
fig
contrast
result
figur
show
ifn
system
ifn
product
ifn
signal
pathway
suppress
sarscov
infect
also
confirm
treatment
sarscov
infect
cell
exogen
ifn
fig
howev
report
littl
induct
beta
ifn
sarscov
infect
macrophag
cheung
et
al
recent
spiegel
et
al
note
sarscov
appear
block
step
earli
nuclear
transport
human
cell
result
ifnb
cell
pretreat
iuml
ifna
ifnb
hr
cell
wash
infect
sarscov
cultiv
day
cultur
medium
harvest
determin
viru
titer
viru
yield
sarscov
calcul
tissu
cultur
infecti
dose
product
differ
data
reason
discrep
still
unclear
may
caus
differ
type
cell
littl
contribut
sarscov
ifn
signal
ifn
consid
suitabl
candid
treatment
sarscov
infect
though
effici
ifn
treatment
sar
patient
ascertain
zhao
et
al
fujii
et
al
vitro
experi
show
signific
affect
ifn
sarscov
replic
cinatl
et
al
lund
et
al
sainz
et
al
also
confirm
higher
antivir
effect
ifnb
ifna
fig
tabl
ii
two
distinct
result
subsequ
suppress
ifn
signal
pathway
rsv
infect
young
et
al
report
rsv
abl
circumv
antivir
function
ifn
replic
human
cell
produc
respond
ifn
without
block
ifn
signal
contrast
ramaswami
et
al
note
rsv
act
epitheli
cell
deriv
airway
modul
inhibit
ifn
signal
transduct
effect
like
mediat
proteasomedepend
degrad
ramaswami
et
al
result
show
induct
isg
suppress
rsv
infect
fig
suggest
rsv
inhibit
ifn
signal
pathway
data
experi
support
result
report
young
et
al
howev
reason
discrep
ramaswami
et
al
find
known
overwhelm
immun
respons
believ
contribut
progress
sar
howev
littl
known
proinflammatori
cytokin
dysregul
clinic
progress
sar
studi
measur
induct
level
sever
cytokin
mrna
cell
infect
sarscov
rsv
fluav
increas
express
rant
found
sarscov
rsv
infect
fluav
overexpress
report
patient
sarscov
rsv
hornsleth
et
al
zhang
et
al
rsv
infect
caus
sever
respiratori
symptom
compar
infect
fluav
serum
concentr
level
rant
correl
symptom
score
sung
et
al
gern
et
al
rant
potent
neutrophil
attract
activ
shown
elev
blood
alveolar
space
cholletmartin
et
al
exhibit
posit
correl
number
chemokin
patient
pneumonia
acut
respiratori
distress
syndrom
villard
et
al
therefor
chemokin
induc
sarscov
may
also
play
role
accumul
hemophagocytosi
lung
develop
subsequ
wheez
sarscov
infect
contribut
symptom
sever
sar
collect
sarscov
infect
significantli
induc
inflammatori
cytokin
chemokin
well
rsv
infect
like
contribut
onset
sever
respiratori
symptom
compar
fluav
infect
howev
clinic
sign
symptom
sarscov
infect
sever
rsv
infect
differ
inflammatori
respons
sarscov
rsv
found
differ
induct
neg
regul
cytokin
signal
soc
famili
induc
level
mrna
sarscov
infect
clearli
lower
rsv
infect
transcript
activ
variou
gene
contribut
inflammatori
respons
neg
factor
particip
feedback
system
signal
transduct
bind
phosphoryl
tyrosin
residu
compon
receptor
yasukawa
et
al
therefor
suppress
express
sarscov
infect
cell
might
lead
continu
activ
prolong
enhanc
signal
less
induct
contribut
dysregul
inflammatori
signal
increas
sever
inflamm
sarscov
infect
stimul
cell
lead
activ
jakstat
mitogenactiv
protein
kinas
mapk
akt
signal
transduct
pathway
yang
et
al
depend
express
promot
activ
jakstat
signal
pathway
lang
et
al
mizutani
et
al
report
sarscov
induc
dephosphoryl
constitut
phosphoryl
result
dysfunct
transcript
activ
inactiv
may
contribut
less
induct
sarscov
infect
therefor
import
investig
influenc
sarscov
phosphorylationdephosphoryl
addit
possibl
direct
affect
promot
region
gene
sarscov
infect
hand
activ
mapk
akt
signal
transduct
pathway
sarscov
mizutani
et
al
c
may
correl
inflammatori
respons
contrast
sarscov
recogn
abund
induct
rsv
infect
downregul
appropri
cytokin
signal
feedback
regul
soc
famili
thought
play
import
role
balanc
cytokin
signal
thu
contribut
onset
mediat
immun
respons
express
correl
patholog
mediat
allerg
immun
diseas
atop
dermat
asthma
seki
et
al
mani
epidemiolog
studi
indic
possibl
linkag
rsv
infect
childhood
subsequ
manifest
atopi
asthma
sigur
et
al
holt
sli
strong
induct
rsv
could
caus
factor
atopi
asthma
studi
underway
investig
correl
induct
cytokin
regul
rsv
infect
fl
cell
detect
protein
cell
infect
rsv
treat
difficulti
protein
detect
thought
depend
cell
type
sarscov
addit
member
soc
famili
ci
also
investig
virus
infect
cell
virus
fail
express
rsv
abl
induc
ci
fig
therefor
ci
play
import
role
inflammatori
system
rsv
infect
increas
express
found
sarscov
rsv
infect
enhanc
interact
tlr
microbi
substanc
potenti
profoundli
alter
grade
inflamm
inde
upregul
rsv
infect
lead
increas
bind
lp
airway
epithelium
enhanc
inflammatori
reaction
monick
et
al
therefor
suggest
sarscov
rsv
infect
enhanc
epitheli
inflammatori
respons
inhal
microbi
substanc
upregul
tlr
conclus
consid
overwhelm
immun
respons
sar
result
dysregul
cytokin
network
caus
overexpress
inflammatori
cytokin
downregul
feedback
regul
studi
use
help
clarif
mechan
clinic
progress
sar
cytokin
regul
system
may
lead
establish
new
therapeut
target
sar
